What’s on the horizon for the treatment of psoriasis?

The Psoriasis and Psoriatic Arthritis Hub was pleased to speak with Peter van de Kerkhof, Radboud University, Nijmegen, NL. We asked, What’s on the horizon for the treatment of psoriasis?

After briefly reviewing the history of psoriasis treatment, with a slide on the key signaling pathways, van der Kerkof discusses novel treatments for psoriasis, such as deucravacitinib, apremilast, and tapinarof. Next, the changing perspectives on the classification of psoriasis as a skin disease or a systemic condition are considered. To read more about the classification of psoriasis, please see our article "An overview of the epidemiology diagnosis classification and management of psoriasis" that be found here: https://psoriasis-hub.com/medical-information/an-overview-of-the-epidemiology-diagnosis-classification-and-management-of-psoriasis